Results 211 to 220 of about 1,766,854 (293)
Editorial: Synaptic plasticity across the lifespan: mechanisms, adaptation, and vulnerability. [PDF]
Guidi S, Inglebert Y, Uguagliati B.
europepmc +1 more source
Disentangling the Genetic Relationship Between Sleep and Epilepsy
ABSTRACT Objective A bidirectional relationship between sleep and epilepsy is well recognised, yet the biological mechanisms linking them remain poorly understood. Both have a genetic basis, with genome‐wide association studies (GWAS) capturing polygenic contributions.
Khang N. Le +9 more
wiley +1 more source
Acute Endocrine Alterations After Traumatic Brain Injury and 6‐Month Functional Outcome
ABSTRACT Objective Acute multi‐axis endocrine alterations after traumatic brain injury (TBI) remain incompletely characterized. This study aimed to examine their temporal patterns and explore their associations with 6‐month functional outcome and early inflammatory markers.
Biao Xu +9 more
wiley +1 more source
Editorial: Unraveling the mechanisms of psychiatry disorders. [PDF]
Soto-Montenegro ML +2 more
europepmc +1 more source
ABSTRACT Background While autoimmune encephalitis (AE) outcomes vary, serostatus‐specific prognostic determinants and institutional clustering effects remain poorly characterized. We aimed to delineate the distinct prognostic architecture of AE, identifying serostatus‐specific risk factors and potential therapeutic windows.
Xiaohong Tang +17 more
wiley +1 more source
Cerebrospinal Fluid GAD65‐Antibody Levels Accurately Identify Relevant Neurological Diseases
ABSTRACT Retrospective cohort study to investigate which factors most reliably distinguish incidental GAD65‐antibodies (iGAD65) from true GAD65‐antibody neurological disease (tGAD65). 167 adults with positive serum and CSF GAD65‐antibodies (> 0.02 nmol/L by radioimmunoassay) were classified as tGAD65 or iGAD65, with diagnostic performance of ...
Max Charles Herman +9 more
wiley +1 more source
Retraction: Administration of tauroursodeoxycholic acid attenuates early brain injury via Akt pathway activation. [PDF]
Frontiers Editorial Office.
europepmc +1 more source
Objective The objective of this study was to evaluate the real‐world effectiveness and safety of secukinumab in patients with giant cell arteritis (GCA). Methods This multicenter retrospective study included patients with GCA who received secukinumab at 14 Italian centers with at least six months of follow‐up.
Luca Iorio +28 more
wiley +1 more source
Correction: Glutamate imaging reveals multiple sites of stochastic release in the CA3 giant mossy fiber boutons. [PDF]
Rama S, Jensen TP, Rusakov DA.
europepmc +1 more source

